menu
    • menu

    Company profile for ImStem Biotechnology

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Imstem Biotechnology, Inc. [pronounced as "I am stem (cells)"] is a biotechnology company focusing on developing cell therapeutic product derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. With our state-of-art stem cell technologies, we will be able to provide different kinds of therapeutic and research products with ...
    Imstem Biotechnology, Inc. [pronounced as "I am stem (cells)"] is a biotechnology company focusing on developing cell therapeutic product derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. With our state-of-art stem cell technologies, we will be able to provide different kinds of therapeutic and research products with unlimited supply and consistent quality in the near future.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImStem BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Farmington Ave R1808 Farmington,CT , 06030
    Telephone
    Telephone
    860-281-7836
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.imstem.com/index.php?lang=en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rudolf Jaenisch joins ImStem Biotechnology as Member of its Scientific
    Rudolf Jaenisch joins ImStem Biotechnology as Member of its Scientific

    29 Aug 2022

    // EINNEWS

    https://www.einnews.com/pr_news/588228830/prof-rudolf-jaenisch-joins-imstem-biotechnology-as-member-of-its-scientific-advisory-board

    EINNEWS
    29 Aug 2022
    Share Share
    ImStem Begins Dosing in study for IMS001
    ImStem Begins Dosing in study for IMS001

    18 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/imstem-announces-first-us-multiple-sclerosis-patient-has-been-dosed-with-its-ims001-301426858.html

    PRNEWSWIRE
    18 Nov 2021
    Share Share
    AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 to ImStem B
    AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 to ImStem B

    28 Oct 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/agex-therapeutics-sublicenses-stem-cell-line-esi-053-to-imstem-biotechnology-for-development-of-cell-therapy-candidate-ims001-for-covid-19-and-acute-respiratory-distress-syndrome/

    BIOSPACE
    28 Oct 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search